angiopoietin-like 4 (University of California, Berkeley)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameangiopoietin-like 4 (University of California, Berkeley)
Drug Alias NameANGPTL4
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLipoprotein lipase inhibitors
TargetsLipoprotein lipase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A